{
    "organizations": [],
    "uuid": "60d648b8a98ce586269b832041708cb7dde78d10",
    "author": "",
    "url": "https://www.reuters.com/article/brief-arrowhead-pharmaceuticals-announce/brief-arrowhead-pharmaceuticals-announces-pricing-of-underwritten-public-offering-of-common-stock-idUSASB0C1FL",
    "ord_in_thread": 0,
    "title": "BRIEF-Arrowhead Pharmaceuticals Announces Pricing Of Underwritten Public Offering Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 18, 2018 / 2:08 PM / in 11 minutes BRIEF-Arrowhead Pharmaceuticals Announces Pricing Of Underwritten Public Offering Of Common Stock Reuters Staff \nJan 18 (Reuters) - Arrowhead Pharmaceuticals Inc: \n* ARROWHEAD PHARMACEUTICALS ANNOUNCES PRICING OF UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK \n* SAYS PUBLIC OFFERING OF 10.0 MILLION COMMON SHARES PRICED AT $5.25PER SHARE Source text for Eikon: Further company coverage:",
    "published": "2018-01-18T16:07:00.000+02:00",
    "crawled": "2018-01-18T16:22:36.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "pharmaceutical",
        "announces",
        "pricing",
        "underwritten",
        "public",
        "offering",
        "common",
        "stock",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "arrowhead",
        "pharmaceutical",
        "inc",
        "arrowhead",
        "pharmaceutical",
        "announces",
        "pricing",
        "underwritten",
        "public",
        "offering",
        "common",
        "stock",
        "say",
        "public",
        "offering",
        "million",
        "common",
        "share",
        "priced",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}